Table 4 Diseases associated with metabolites in the high-residential radon exposure group compared to the low-residential radon exposure group.
Diseases | Total | Hits | Hits compound | P value |
|---|---|---|---|---|
1. Lung cancer | 9 | 1 | D-Sphingosine | 8.4 × 10−4 |
2. Kidney disease | 28 | 1 | 3-Methylhistidine | 0.003 |
3. Early preeclampsia | 45 | 1 | 3-Methylhistidine | 0.004 |
4. Alzheimer’s disease | 59 | 1 | 3-Methylhistidine | 0.005 |
